NCT03104699 2025-07-30A Study of AGEN2034 in Advanced Tumors and Cervical CancerAgenus Inc.Phase 1/2 Completed211 enrolled 29 charts
NCT04672434 2024-12-09Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSymphogen A/SPhase 1 Completed48 enrolled